ロード中...
Enhanced Passive Safety Surveillance (EPSS) confirms an optimal safety profile of the use of MF59(®)‐adjuvanted influenza vaccine in older adults: Results from three consecutive seasons
BACKGROUND: In Europe, the enhanced safety surveillance (ESS) of seasonal influenza vaccines is mandatory, in order to detect any potential increase in reactogenicity when the vaccine composition is updated. The MF59(®)‐adjuvanted influenza vaccine (Fluad™) is the first and the only licensed adjuvan...
保存先:
| 出版年: | Influenza Other Respir Viruses |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
John Wiley and Sons Inc.
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6928029/ https://ncbi.nlm.nih.gov/pubmed/31617965 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/irv.12685 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|